Glipizide controlled release tablet and preparation method thereof

A technology of glipizide and controlled-release tablets, which is applied in pharmaceutical formulations, medical preparations of non-active ingredients, drug delivery, etc., can solve the problems of laser intensity attenuation, unstable quality, and high manufacturing costs, and achieve improved solubility , meet the needs of drug administration, and reduce production costs

Pending Publication Date: 2021-04-20
南京易亨制药有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantages are: laser perforation equipment is very expensive, the manufacturing cost is high, and in the mass production process, it is limited by the cycle time of laser light speed irradiation, and the attenuation of laser intensity can easily cause batch-to-batch differences and unstable quality
The disadvantages are: laser drilling is required, the manufacturing cost is high, and the mass production speed will be limited to a certain extent. In addition, it is necessary to control the laser perforation on the surface of the semi-permeable film coat measured on the drug layer, which further increases the complexity of the preparation process.
The disadvantages are: laser drilling is required, the manufacturing cost is high, and the product quality is greatly affected by the attenuation of laser intensity
[0012] Although the relevant preparation processes provided above are beneficial to improve the storage period of the product and realize industrialized production to a certain extent, these processes are for the controlled-release tablets of glipizide-controlled drugs. The laser perforation equipment used in the drug channel is very expensive, and the manufacturing cost is high. In the mass production process, it is limited by the cycle time of laser light speed irradiation, and the attenuation of laser intensity can easily cause batch-to-batch differences and unstable quality.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glipizide controlled release tablet and preparation method thereof
  • Glipizide controlled release tablet and preparation method thereof
  • Glipizide controlled release tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] A kind of preparation method of glipizide controlled-release tablet in the present embodiment comprises the following steps:

[0055] 1) Drug-containing layer

[0056] Put the prescribed amount of polyvinylpyrrolidone K30 and the prescribed amount of glipizide into a low-shear V-type mixer for mixing, mix for 30 minutes to obtain a mixed powder, and then prepare the mixed powder by hot-melt extrusion to prepare a solid dispersion. Crush, sieve, the particle size range is 75-250μm, add the prescribed amount of sodium chloride and magnesium stearate to the prescribed amount of solid dispersion powder, mix in a low-shear V-type mixer, and mix for 30min. The mixed powder of the drug-containing layer is obtained.

[0057] 2) booster layer

[0058] Put the prescribed amount of polyvinylpyrrolidone K30 and sodium chloride into a low-shear V-shaped mixer for mixing, mix for 30 minutes, add the prescribed amount of magnesium stearate, and then mix in a low-shear V-shaped mixer...

Embodiment 2

[0066] A kind of preparation method of glipizide controlled-release tablet in the present embodiment comprises the following steps:

[0067] 1) Drug-containing layer

[0068] Put the prescribed amount of polyvinylpyrrolidone K30 and the prescribed amount of glipizide into a low-shear V-type mixer for mixing, mix for 30 minutes to obtain a mixed powder, and then prepare the mixed powder by hot-melt extrusion to prepare a solid dispersion. Crush, sieve, the particle size range is 75-250μm, add the prescribed amount of hypromellose, sodium chloride and magnesium stearate to the prescribed amount of solid dispersion powder, in a low-shear V-type mixer Mixed for 30 minutes to obtain the mixed powder of the drug-containing layer.

[0069] 2) booster layer

[0070] Put the prescribed amount of polyvinylpyrrolidone K30 and sodium chloride into a low-shear V-shaped mixer for mixing, mix for 30 minutes, add the prescribed amount of magnesium stearate, and then mix in a low-shear V-sha...

Embodiment 3

[0079] A kind of preparation method of glipizide controlled-release tablet in the present embodiment comprises the following steps:

[0080] 1) Drug-containing layer

[0081] Put the prescribed amount of polyvinylpyrrolidone K30 and the prescribed amount of glipizide into a low-shear V-type mixer for mixing, mix for 30 minutes to obtain a mixed powder, and then prepare the mixed powder by hot-melt extrusion to prepare a solid dispersion. Crush, sieve, the particle size range is 75-250μm, add the prescribed amount of hypromellose, sodium chloride and magnesium stearate to the prescribed amount of solid dispersion powder, in a low-shear V-type mixer Mixed for 30 minutes to obtain the mixed powder of the drug-containing layer.

[0082] 2) booster layer

[0083] Put the prescribed amount of polyvinylpyrrolidone K30 and sodium chloride into a low-shear V-shaped mixer for mixing, mix for 30 minutes, add the prescribed amount of magnesium stearate, and then mix in a low-shear V-sha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention belongs to the field of pharmaceutical preparations, and particularly relates to a glipizide controlled release tablet and a preparation method thereof. The preparation method comprises the steps of mixing together a water-soluble matrix component with the moderate glass transition temperature for hot melt extrusion, and then mixing prepared solid dispersion with one or more adhesives; mixing an osmotic pressure promoter in a boosting layer, one or more adhesives, and optionally, a lubricant; and respectively pouring total mixed particles of a drug-containing layer and the boosting layer into a hopper, tabletting by adopting a tablet press cast with shallow dents, firstly pressing the drug-containing layer, then pressing the boosting layer, enabling the shallow dents to be positioned on the surface of the drug-containing layer, and then coating with a semipermeable membrane coating, so as to realize the continuous release of the glipizide controlled release tablet and have an acceptable dissolution curve.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a glipizide controlled-release tablet and a preparation method thereof. Background technique [0002] Glipizide is a second-generation sulfonylurea oral hypoglycemic agent. It mainly promotes the secretion of insulin by pancreatic β cells, especially the glucose-stimulated insulin secretion. It also enhances the action of insulin, thereby effectively reducing blood sugar concentration and glycosylated hemoglobin; it can also improve hyperlipidemia, reduce triglyceride and cholesterol levels, and increase the ratio of high-density lipoprotein cholesterol in total cholesterol; it can also inhibit platelets Aggregation and promotion of fibrinolysis, so it may have a certain preventive effect on vascular lesions. In 1984, Pfizer's trade name drug Glucotrol was listed for the first time, including a variety of specifications. In addition, there are many companies in the U...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/22A61K9/36A61K9/32A61K31/64A61K47/32A61P3/10A61P5/50A61P3/06
Inventor 朱学东陈女贞封思阳周礼明
Owner 南京易亨制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products